CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Derivatives Options or other derivatives
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Executive or director change · Bylaws or fiscal year change · Shell status change
- 4 Open-market buy President, CEO and Director bought 1,522,500 shares at $10.00 ($15,225,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,522,500 shares at $10.00 ($15,225,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 1,522,500 shares at $10.00 ($15,225,000)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 49,986 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Surgical Officer acquired 7,877 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 2,625 shares (grant or award)
Page 21 of 26 · 506 filings